Sebia USA Revenue and Competitors

Atlanta, GA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Sebia USA's estimated annual revenue is currently $22.1M per year.(i)
  • Sebia USA's estimated revenue per employee is $251,000

Employee Data

  • Sebia USA has 88 Employees.(i)
  • Sebia USA grew their employee count by 1% last year.

Sebia USA's People

NameTitleEmail/Phone
1
Spécialiste Qualité Produits InstrumentsReveal Email/Phone
2
Field Application SpecialistReveal Email/Phone
3
Spécialiste applicationsReveal Email/Phone
4
Field Service Engineer (Electrical and Electronic Engineer)Reveal Email/Phone
5
Area Sales ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.3M29N/AN/AN/A
#2
$104.7M4173%N/AN/A
#3
$6M24-23%N/AN/A
#4
$5M400%$16MN/A
#5
$6M24-23%N/AN/A
#6
$10.8M435%N/AN/A
#7
$3M240%$50MN/A
#8
$10M40-13%N/AN/A
#9
$5M2011%N/AN/A
#10
$17.6M703%N/AN/A
Add Company

What Is Sebia USA?

Sebia is the world?s leading provider of clinical protein electrophoresis equipment and reagents, a technology used for in-vitro diagnostic (IVD) testing. Its systems analyze protein in order to screen and monitor various diseases and conditions; primarily oncology (Multiple Myeloma), metabolic disorders such as Diabetes and also Hemoglobinopathy and rare pathologies.

keywords:N/A

N/A

Total Funding

88

Number of Employees

$22.1M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sebia USA News

2022-04-19 - Electrophoresis Equipment Market Size, Outlook And Forecast ...

New Jersey, United States – This Electrophoresis Equipment Market ... Perkin Elmer, Sebia, SERVA Electrophoresis, Shimadzu, Takara Bio,...

2022-04-17 - Automated Capillary Electrophoresis Equipment Market Size ...

New Jersey, United States – This Automated Capillary Electrophoresis Equipment Market ... SCIEX, Bio-Rad, Sebia, Helena Laboratories, SCIEX.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18M882%N/A
#2
$28.6M882%N/A
#3
$7.5M901%N/A
#4
$19.3M9230%N/A
#5
$9.3M936%N/A